Numerous studies, using high-glucose concentrations or pharmacological treatments on cultured cells, as well as transgenic animals overexpressing OGT or GFAT, indicated that chronic increases in O-GlcNAcylation can have deleterious effects and promote phenotypes reminiscent of pathologies such as obesity and type 2 diabetes. The gene discussed is OGT; the disease is Obesity.